Rabbit Recombinant Monoclonal CBX8 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 1 publication.
Preservative: 0.01% Sodium azide
Constituents: 59.94% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
ICC/IF | IP | ChIP | WB | IHC-P | Flow Cyt (Intra) | |
---|---|---|---|---|---|---|
Human | Not recommended | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species Rat | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility.
PC3, RC1, CBX8, Chromobox protein homolog 8, Polycomb 3 homolog, Rectachrome 1, Pc3, hPc3
Rabbit Recombinant Monoclonal CBX8 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 1 publication.
Preservative: 0.01% Sodium azide
Constituents: 59.94% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Cbx8 also known as Chromobox protein homolog 8 is part of the Polycomb group proteins with a molecular mass of approximately 50 kDa. Cbx8 functions as a transcriptional regulator by binding to histones and repressive chromatin states. It has a broad expression including in embryonic stem cells and various adult tissues. Its involvement extends to chromatin modification and impacts gene expression regulation making it significant in controlling cellular identity and differentiation.
Cbx8 contributes to the regulation of gene silencing within the Polycomb Repressive Complex 1 (PRC1). It plays an important role in maintaining cellular memory by ensuring heritable transcriptional repression of target genes. Cbx8's involvement in histone modification particularly histone H3 lysine 27 trimethylation (H3K27me3) is a part of its mechanism to regulate gene expression. This regulation affects key developmental processes and signals cellular differentiation pathways critical for tissue development and maintenance.
Cbx8 engages in the Polycomb pathway where it interacts with other PRC1 proteins playing a role in chromatin compaction and silencing of developmental genes. It associates with pathways involved in cell cycle regulation and differentiation linking to essential proteins like RING1 and BMI1. These interactions enable Cbx8 to influence the transcriptional repression necessary for proper execution of developmental programs and cellular response to external signals.
Cbx8 has affiliations with cancer and developmental disorders due to its role in gene silencing. Abnormal Cbx8 activity may lead to disruptions in normal cell cycle controls contributing to oncogenesis with other PRC1 members like BMI1. It also connects to certain developmental syndromes where polycomb dysfunction impacts normal tissue development indicating its broader significance in maintaining cellular homeostasis and genomic stability.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Incubation for primary antibody was carried out overnight at 4 degree.
This blot was developed using a higher sensitivity ECL substrate.
Exposure time: 48 seconds
All lanes: Western blot - Anti-Cbx8 antibody [EPR23800-14] (ab259849) at 1/1000 dilution
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 40 µg
Lane 2: 293T (human embryonic kidney epithelial cell) whole cell lysate at 40 µg
Lane 3: Huh7 (human hepatocellar carcinoma epithelial cell) whole cell lysate at 40 µg
Lane 4: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 40 µg
Lane 5: C6 (rat glial tumor glial cell) whole cell lysate at 40 µg
All lanes: Western blot - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/1000 dilution
Predicted band size: 43 kDa
Observed band size: 43 kDa, 48 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com